Illumina, NRGene Collaborate to Accelerate Development of New Molecular...
SAN DIEGO & NESS ZIONA, Israel--( )--Jan. 12, 2017-- Illumina, Inc. read more
View ArticleIllumina Debuts VeriSeq Analysis Software (48 Samples), Optimized Data...
SAN DIEGO--( )--Jan. 30, 2017-- Illumina, Inc. (NASDAQ: ILMN) today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded...
View ArticleIllumina Names John W. Thompson to Its Board of Directors, Bringing More Than...
SAN DIEGO--( )--Feb. 20, 2017-- Illumina, Inc. (NASDAQ: ILMN) announced today that John W. Thompson will join the company’s Board of Directors on May 3, 2017, bringing extensive technology leadership...
View ArticleIllumina Announces the iHope Network, an Expansion of Its iHope Philanthropic...
SAN DIEGO--( )--Feb. 28, 2017-- Illumina, Inc. (NASDAQ:ILMN) today announced the launch of the iHope Network, a consortium of member institutions who have committed to providing clinical whole genome...
View ArticleIllumina Advances the Use of Genomics in Precision Oncology, Donates...
SAN DIEGO--( )--Apr. 3, 2017-- Illumina, Inc. read more
View ArticleIllumina Launches the VeriSeq NIPT Solution in Europe
SAN DIEGO--( )--Apr. 10, 2017-- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the VeriSeq™ NIPT Solution, a CE-IVD marked next-generation sequencing (NGS)-based approach to noninvasive...
View ArticleIllumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings...
SAN DIEGO--( )--May 22, 2017-- Illumina, Inc. (NASDAQ: ILMN) announced today that Mark Van Oene has been named Chief Commercial Officer. Van Oene was previously Illumina’s Senior Vice President of the...
View ArticleGenomics England Adopts Illuminas BaseSpace Variant Interpreter for Cancer
SAN DIEGO--( )--Jun. 26, 2017-- Illumina, Inc. read more
View ArticleIllumina Announces FDA-approved Next-Generation Sequencing Cancer Companion...
SAN DIEGO--( )--Jun. 29, 2017-- Illumina, Inc. read more
View ArticleIllumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption...
SAN DIEGO--( )--Aug. 24, 2017-- Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish...
View ArticleIllumina Files New Patent Infringement Suit Against Premaitha Health plc
SAN DIEGO--( )--Sep. 7, 2017-- Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery...
View ArticleIllumina Releases NovaSeq S4 Flow Cell and NovaSeq Xp Workflow
SAN DIEGO--( )--Oct. 16, 2017-- Illumina, Inc. read more
View ArticleIllumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding...
SAN DIEGO--( )--Nov. 8, 2017-- Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S. Guthart will join the company’s Board of Directors on December 1, 2017. Dr. Guthart is President and Chief...
View ArticleIllumina Grows Clinical IVD Portfolio with Introduction of NextSeq 550Dx...
Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system. The...
View ArticleIllumina Wins Infringement Suit Against Premaitha Health plc and Ariosa...
SAN DIEGO--( )--Nov. 21, 2017-- Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in...
View ArticleIllumina Opens First Commercial and Customer Training Center in France
PARIS--( )--Nov. 29, 2017-- Illumina, Inc. (NASDAQ:ILMN) today announced the opening of its Solutions Center on the Genopole Campus in Évry, near Paris. read more
View ArticleIllumina Names Aimee Hoyt Chief People Officer, Bringing 20+ Years of Senior...
SAN DIEGO--( )--Dec. 11, 2017-- Illumina, Inc. read more
View ArticleIllumina and KingMed Diagnostics Partner to Develop Next-Generation...
SAN DIEGO--( )--Jan. 4, 2018-- Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing...
View ArticleThermo Fisher Scientific and Illumina Sign Agreement to Provide Research...
CARLSBAD, Calif. & SAN DIEGO--( )--Jan. 8, 2018-- Thermo Fisher Scientific and Illumina, Inc. read more
View ArticleIllumina Launches iSeq 100 Sequencing System
SAN DIEGO--( )--Jan. 8, 2018-- Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional data...
View Article
